Production (Stage)
AxoGen, Inc.
AXGN
$11.07
$0.131.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 194.52M | 187.34M | 180.86M | 173.48M | 163.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 194.52M | 187.34M | 180.86M | 173.48M | 163.73M |
| Cost of Revenue | 50.23M | 45.36M | 44.43M | 41.79M | 37.73M |
| Gross Profit | 144.29M | 141.98M | 136.42M | 131.69M | 126.00M |
| SG&A Expenses | 118.23M | 117.50M | 116.68M | 115.96M | 116.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 194.91M | 190.63M | 189.35M | 185.69M | 182.41M |
| Operating Income | -388.00K | -3.29M | -8.50M | -12.21M | -18.68M |
| Income Before Tax | -7.16M | -9.96M | -14.31M | -16.54M | -21.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.16 | -9.96 | -14.31 | -16.54 | -21.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.16M | -9.96M | -14.31M | -16.54M | -21.28M |
| EBIT | -388.00K | -3.29M | -8.50M | -12.21M | -18.68M |
| EBITDA | 6.56M | 3.45M | -1.85M | -6.05M | -13.39M |
| EPS Basic | -0.16 | -0.23 | -0.33 | -0.38 | -0.49 |
| Normalized Basic EPS | -0.10 | -0.14 | -0.21 | -0.24 | -0.31 |
| EPS Diluted | -0.16 | -0.23 | -0.33 | -0.39 | -0.50 |
| Normalized Diluted EPS | -0.10 | -0.14 | -0.21 | -0.24 | -0.31 |
| Average Basic Shares Outstanding | 177.68M | 175.71M | 173.88M | 173.02M | 172.17M |
| Average Diluted Shares Outstanding | 180.86M | 178.89M | 173.88M | 173.02M | 172.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |